3.1.6.13: iduronate-2-sulfatase
This is an abbreviated version!
For detailed information about iduronate-2-sulfatase, go to the full flat file.
Word Map on EC 3.1.6.13
-
3.1.6.13
-
mucopolysaccharidosis
-
lysosomal
-
glycosaminoglycans
-
x-linked
-
dermatan
-
heparan
-
multisystemic
-
sulfatases
-
hepatosplenomegaly
-
medicine
-
arylsulfatase
-
mpsii
-
x-chromosome
-
enzyme-replacement
-
analysis
-
synthesis
-
alpha-l-iduronidase
-
neuronopathic
-
infusion-related
-
drug development
-
6-minute
-
dysostosis
-
diagnostics
-
shire
-
hurler
- 3.1.6.13
- mucopolysaccharidosis
- lysosomal
- glycosaminoglycans
-
x-linked
- dermatan
- heparan
-
multisystemic
-
sulfatases
-
hepatosplenomegaly
- medicine
- arylsulfatase
-
mpsii
-
x-chromosome
-
enzyme-replacement
- analysis
- synthesis
- alpha-l-iduronidase
-
neuronopathic
-
infusion-related
- drug development
-
6-minute
- dysostosis
- diagnostics
-
shire
- hurler
Reaction
Synonyms
2-sulfo-L-iduronate 2-sulfatase, chondroitinsulfatase, elaprase, Hunter corrective factor, I2S, IDS, IDS-Like, IDS-like enzyme, iduronate 2-sulfatase, iduronate 2-sulfate sulfatase-like, iduronate 2-sulfate-like enzyme, iduronate sulfatase, iduronate sulfate sulfatase, iduronate-2-sulfatase, iduronate-2-sulfate sulfatase, iduronate-2-sulphatase, iduronide-2-sulfate sulfatase, idurono-2-sulfatase, idursulfase, L-iduronate 2-sulfate sulfatase, L-idurono sulfate sulfatase, sulfatase, L-idurono-, sulfo-L-iduronate sulfatase, sulfoiduronate sulfohydrolase
ECTree
Advanced search results
Crystallization
Crystallization on EC 3.1.6.13 - iduronate-2-sulfatase
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
structural models of the wild type and mutant IDS proteins resulting from 131 missense mutations identified in patients with mucopolysaccharidosis MPS II. The amino acid substitutions causing MPS II are widely spread over the enzyme molecule and the structural changes of the enzyme protein are generally larger in the severe group than in the attenuated one. The structural changes influence the disease progression
structure with a covalently bound sulfate ion in the active site, to 2.3 A resolution